Related Experiment Video
Updated: Apr 24, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Steatotic liver disease and chronic viral hepatitis
Jakub Janczura1, Alessandra Mangia2, Krystyna Dobrowolska1
1Collegium Medicum, Jan Kochanowski University, Kielce, Poland.
None:
Steatotic liver disease (SLD) is a condition characterized by excessive fat accumulation within hepatocytes. In recent years, the nomenclature and diagnostic framework of the disease have evolved and the term SLD has replaced the previous fatty liver disease classification. This change reflects a more inclusive understanding of the metabolic drivers of the disease and its strong association with systemic conditions. With the rising global prevalence of metabolic disorders, the burden of SLD has increased significantly, making it the leading cause of chronic liver disease worldwide. While many cases of SLD remain non-progressive, metabolic dysfunction associated steatohepatitis (MASH) may advance to fibrosis, cirrhosis, or hepatocellular carcinoma. The risk of disease progression may be greater when liver steatosis coexists with other hepatic insults, particularly chronic infections with hepatitis B virus or hepatitis C virus. This review explores the prevalence, interactions, and therapeutic implications of SLD in patients with chronic viral hepatitis.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis II: Pathophysiology
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis I: Introduction
Chronic Pancreatitis II: Pathophysiology

